Welcome to EPEX SPOT!

General conditions

Any user of this website expressly agrees to the Conditions of Use published in the Privacy Notice and the Usage of Website.

 

Market Data Use

The content of the Website is to be used exclusively for internal reasons. Commercial usage is only allowed after explicit approval of EPEX SPOT. Please click here for General Conditions of Data Use.


RE: XBID – 2nd Wave Go-Live and Changes in Gate Opening Time from 1st January 2019

Over 6.3 million trades completed in XBID. Expansion of XBID into further countries expected summer 2019. Harmonisation of Gate Opening Times from 1st January 2019 will be communicated locally by Transmission System Operators.

Paris, 05. December 2018. The XBID parties are pleased to confirm that XBID continues to operate with stability and that over 6.3 million trades have been successfully completed since go-live in June. The XBID solution has been operational for nearly 6 months.

Preparations are now underway for a 2nd wave go-live which is expected to be launched in 2019. The following countries are actively involved in this expansion: Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania and Slovenia, together with the bordering countries who are already operational from the 1st go-live. The borders which will take part in this 2nd wave go-live will be confirmed in spring 2019.

Gate Opening Times (GOT) are expected to be changed to 15:00 CET, D-1 according to the ACER decision No. 04/2018 of 24 April 2018 for intraday cross-zonal gate opening and closure times. Many of these changes are expected to be in operation as of 1st January 2019. In capacity calculation regions (CCRs) where the capacity calculation methodology has not been approved yet, the implementation date will be, at the latest, 30 days after National Regulatory Authority’s approval. Details on the timing and available capacities, including a reasoning in case cross-zonal capacity can only be released after GOT, will be provided separately by Transmission System Operators on the CCR level.